4.5 Article

Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasiveness

Journal

NATURE STRUCTURAL & MOLECULAR BIOLOGY
Volume 19, Issue 11, Pages 1139-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nsmb.2390

Keywords

-

Funding

  1. Institut National du Cancer [2008-1-PL BIO 01]
  2. Agence Nationale de la Recherche [BLAN07-3_186592]
  3. Association d'Aide a la Recherche Cancerologique de Saint-Cloud
  4. Fondation Recherche Medicale [Equipe FRM DEQ20110421278]
  5. Association pour la Recherche sur le Cancer
  6. FRM
  7. Ligue Nationale Contre le Cancer
  8. Association Francaise contre les Myopathies

Ask authors/readers for more resources

Both epigenetic and splicing regulation contribute to tumor progression, but the potential links between these two levels of gene-expression regulation in pathogenesis are not well understood. Here, we report that the mouse and human RNA helicases Ddx17 and Ddx5 contribute to tumor-cell invasiveness by regulating alternative splicing of several DNA-and chromatin-binding factors, including the macroH2A1 histone. We show that macroH2A1 splicing isoforms differentially regulate the transcription of a set of genes involved in redox metabolism. In particular, the SOD3 gene that encodes the extracellular superoxide dismutase and plays a part in cell migration is regulated in an opposite manner by macroH2A1 splicing isoforms. These findings reveal a new regulatory pathway in which splicing factors control the expression of histone variant isoforms that in turn drive a transcription program to switch tumor cells to an invasive phenotype.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available